(Q36108778)

12 August 2017

1 reference

title

Tuberous sclerosis and the kidney: from mesenchyme to epithelium, and beyond (English)

1 reference

12 August 2017

1 reference

Elizabeth Petri Henske

series ordinal

1

1 reference

12 August 2017

26 April 2005

1 reference

12 August 2017

1 reference

12 August 2017

20

1 reference

12 August 2017

854-857

1 reference

12 August 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-004-1795-3

12 August 2017

0 references

cites work

Causes of Death in Patients With Tuberous Sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00467-004-1795-3

Identification and characterization of the tuberous sclerosis gene on chromosome 16

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-004-1795-3

Polycystic kidney disease as a result of loss of the tuberous sclerosis 2 tumor suppressor gene during development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-004-1795-3

Renal angiomyolipomas from patients with sporadic lymphangiomyomatosis contain both neoplastic and non-neoplastic vascular structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-004-1795-3

The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho

21 January 2018

1 reference

12 December 2020

Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs

1 reference

12 December 2020

TSC2 regulates VEGF through mTOR-dependent and -independent pathways

1 reference

12 December 2020

Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis.

1 reference

12 December 2020

Rheb is in a high activation state and inhibits B-Raf kinase in mammalian cells

1 reference

12 December 2020

Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways

1 reference

12 December 2020

Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions

1 reference

12 December 2020

Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression

1 reference

12 December 2020

Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration

1 reference

12 December 2020

Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products

1 reference

12 December 2020

Renal lesion growth in children with tuberous sclerosis complex

1 reference

12 December 2020

Tuberous sclerosis with cystic renal disease and multifocal renal cell carcinoma in a baby girl

1 reference

12 December 2020

Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma

1 reference

12 December 2020

Apparent renal cell carcinomas in tuberous sclerosis are heterogeneous: the identification of malignant epithelioid angiomyolipoma

1 reference

12 December 2020

TSC2 mediates cellular energy response to control cell growth and survival

1 reference

12 December 2020

Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex.

1 reference

12 December 2020

Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles

1 reference

12 December 2020

Carcinomalike monotypic epithelioid angiomyolipoma in patients without evidence of tuberous sclerosis: a clinicopathologic and genetic study.

1 reference

12 December 2020

Mutational analysis of the von hippel lindau gene in clear cell renal carcinomas from tuberous sclerosis complex patients.

1 reference

12 December 2020

The genetic basis of cancer of the kidney

1 reference

12 December 2020

Regulation of B-Raf kinase activity by tuberin and Rheb is mammalian target of rapamycin (mTOR)-independent

1 reference

12 December 2020

Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.

1 reference

12 December 2020

Cell cycle-regulated phosphorylation of hamartin, the product of the tuberous sclerosis complex 1 gene, by cyclin-dependent kinase 1/cyclin B

1 reference

12 December 2020

Tuberous sclerosis-associated renal cell carcinoma. Clinical, pathological, and genetic features

1 reference

12 December 2020

Tuberin-dependent membrane localization of polycystin-1: a functional link between polycystic kidney disease and the TSC2 tumor suppressor gene

1 reference

12 December 2020

Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis

1 reference

12 December 2020

Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions

1 reference

12 December 2020

Malignant renal tumors in tuberous sclerosis

1 reference

12 December 2020

Meta analysis of the relationship between tuberous sclerosis complex and renal cell carcinoma

1 reference

12 December 2020

Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease--a contiguous gene syndrome

1 reference

12 December 2020

Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients.

1 reference

12 December 2020

9q34 loss of heterozygosity in a tuberous sclerosis astrocytoma suggests a growth suppressor-like activity also for the TSC1 gene

1 reference

12 December 2020

Renal angiomyolipomata.

1 reference

12 December 2020

Renal cell carcinoma in association with tuberous sclerosis in children

1 reference

12 December 2020

Renal Angiomyolipoma With Epithelioid Sarcomatous Transformation and Metastases

1 reference

12 December 2020

The tuberous sclerosis gene on chromosome 9q34 acts as a growth suppressor

1 reference

12 December 2020

Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34

1 reference

12 December 2020

10.1007/S00467-004-1795-3

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

15856327